BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34387762)

  • 1. Genomic landscape of a mouse model of diffuse-type gastric adenocarcinoma.
    Zhang M; Sugita I; Komura D; Katoh H; Shimada S; Inazawa J; Tanaka S; Ishikawa S
    Gastric Cancer; 2022 Jan; 25(1):83-95. PubMed ID: 34387762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperativity of E-cadherin and Smad4 loss to promote diffuse-type gastric adenocarcinoma and metastasis.
    Park JW; Jang SH; Park DM; Lim NJ; Deng C; Kim DY; Green JE; Kim HK
    Mol Cancer Res; 2014 Aug; 12(8):1088-99. PubMed ID: 24784840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive characterization of the genomic alterations in human gastric cancer.
    Cui J; Yin Y; Ma Q; Wang G; Olman V; Zhang Y; Chou WC; Hong CS; Zhang C; Cao S; Mao X; Li Y; Qin S; Zhao S; Jiang J; Hastings P; Li F; Xu Y
    Int J Cancer; 2015 Jul; 137(1):86-95. PubMed ID: 25422082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic alterations in gastric cancers discovered via whole-exome sequencing.
    Zhang J; Qiu W; Liu H; Qian C; Liu D; Wang H; Hu N; Tang YT; Sun J; Shen Z
    BMC Cancer; 2018 Dec; 18(1):1270. PubMed ID: 30567531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model.
    Rotkrua P; Shimada S; Mogushi K; Akiyama Y; Tanaka H; Yuasa Y
    Br J Cancer; 2013 Mar; 108(4):932-40. PubMed ID: 23385731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic Mutational Landscape in Mexican Patients:
    Cerrato-Izaguirre D; Chirino YI; Prada D; Quezada-Maldonado EM; Herrera LA; Hernández-Guerrero A; Alonso-Larraga JO; Herrera-Goepfert R; Oñate-Ocaña LF; Cantú-de-León D; Meneses-García A; Basurto-Lozada P; Robles-Espinoza CD; Camacho J; García-Cuellar CM; Sánchez-Pérez Y
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic alterations in diffuse-type gastric cancer as shown by high-resolution comparative genomic hybridization.
    Takeno SS; Leal MF; Lisboa LC; Lipay MV; Khayat AS; Assumpção PP; Burbano RR; Smith Mde A
    Cancer Genet Cytogenet; 2009 Apr; 190(1):1-7. PubMed ID: 19264226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of gastric cancer.
    El-Rifai W; Powell SM
    Semin Radiat Oncol; 2002 Apr; 12(2):128-40. PubMed ID: 11979414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic instability and DNA ploidy are linked to DNA copy number aberrations of 8p23 and 22q11.23 in gastric cancers.
    Kawauchi S; Furuay T; Uchiyama T; Adachi A; Okada T; Nakao M; Oga A; Uchida K; Sasaki K
    Int J Mol Med; 2010 Sep; 26(3):333-9. PubMed ID: 20664948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
    Seidlitz T; Chen YT; Uhlemann H; Schölch S; Kochall S; Merker SR; Klimova A; Hennig A; Schweitzer C; Pape K; Baretton GB; Welsch T; Aust DE; Weitz J; Koo BK; Stange DE
    Gastroenterology; 2019 Dec; 157(6):1599-1614.e2. PubMed ID: 31585123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.
    Shimada S; Akiyama Y; Mogushi K; Ishigami-Yuasa M; Kagechika H; Nagasaki H; Fukamachi H; Yuasa Y; Tanaka S
    Br J Cancer; 2018 Apr; 118(7):972-984. PubMed ID: 29527007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
    Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
    BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes.
    Myllykangas S; Junnila S; Kokkola A; Autio R; Scheinin I; Kiviluoto T; Karjalainen-Lindsberg ML; Hollmén J; Knuutila S; Puolakkainen P; Monni O
    Int J Cancer; 2008 Aug; 123(4):817-25. PubMed ID: 18506690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA copy number changes in gastric adenocarcinomas: high resolution-comparative genomic hybridization study in Turkey.
    Gümüs-Akay G; Unal AE; Elhan AH; Bayar S; Karadayt K; Sunguroglu A; Kadikiran A; Tükün A
    Arch Med Res; 2009 Oct; 40(7):551-60. PubMed ID: 20082868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide variants within the IQGAP1 gene in diffuse-type gastric cancers.
    Morris LE; Bloom GS; Frierson HF; Powell SM
    Genes Chromosomes Cancer; 2005 Mar; 42(3):280-6. PubMed ID: 15611933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer.
    Fan B; Dachrut S; Coral H; Yuen ST; Chu KM; Law S; Zhang L; Ji J; Leung SY; Chen X
    PLoS One; 2012; 7(4):e29824. PubMed ID: 22539939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer.
    Oze I; Shimada S; Nagasaki H; Akiyama Y; Watanabe M; Yatabe Y; Matsuo K; Yuasa Y
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):551-554. PubMed ID: 27909811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genomic landscape of oesophagogastric junctional adenocarcinoma.
    Chong IY; Cunningham D; Barber LJ; Campbell J; Chen L; Kozarewa I; Fenwick K; Assiotis I; Guettler S; Garcia-Murillas I; Awan S; Lambros M; Starling N; Wotherspoon A; Stamp G; Gonzalez-de-Castro D; Benson M; Chau I; Hulkki S; Nohadani M; Eltahir Z; Lemnrau A; Orr N; Rao S; Lord CJ; Ashworth A
    J Pathol; 2013 Nov; 231(3):301-10. PubMed ID: 24308032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
    Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
    Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.